Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan

Published:2023-07-14 Issue:1 Volume:26 Page:886-893
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Mizushima Daisuke¹^ORCID,Nagai Yoshino²,Mezzio Dylan³,Harada Keisuke²,Piao Yi²,Barnieh Lianne⁴^ORCID,El Moustaid Fadoua⁴,Cawson Matthew⁴^ORCID,Taniguchi Toshibumi⁵

Affiliation:

1. AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

2. Gilead Sciences, Tokyo, Japan

3. Gilead Sciences, Foster City, USA

4. Maple Health Group, New York (NY), USA

5. Chiba University Hospital, Chiba, Japan

Funder

Gilead Sciences

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2233824

Reference45 articles.

1. World Health Organization. HIV 2022 [October 18 2022]. Available from: https://www.who.int/data/gho/data/themes/hiv-aids.

2. Estimating the incidence and diagnosed proportion of HIV infections in Japan: a statistical modeling study

3. HIV/AIDS in Japan. 2019;National Institute of Infectious Diseases;IASR,2021

4. MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication

5. Assessment of HIV prevalence among MSM in Tokyo using self-collected dried blood spots delivered through the postal service

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in HIV management and challenges in Japan: Current situation of pre-exposure prophylaxis in Tokyo, Japan;Global Health & Medicine;2024

2. Efficacy and Safety of Pre-Exposure Prophylaxis to Control HIV and Sexually Transmitted Infection Among Men Who Have Sex With Men: Protocol for a Single-Arm Interventional Study;JMIR Research Protocols;2023-11-15